Sara Diagnosed with Congenital Obesity Due to Leptin Defect

Congenital obesity caused by a genetic defect involving the leptin hormone requires navigating complex medical diagnoses and delayed treatment pathways. According to an account published on Mamaplaats by creator Melanie, her daughter Sara received a diagnosis of congenital obesity after a lengthy genetic testing process that revealed a missing leptin protein, which normally signals satiety.

Genetic Testing and Initial Diagnosis

Medical examinations showed that Sara lacks the leptin substance responsible for feelings of fullness, yet her eating habits did not match typical expectations for the condition. Melanie reported that Sara is actually quite selective about food and manages normal daily meals without constant requests for eating or behavioral distress. Alongside the missing satiety hormone, doctors determined that Sara’s metabolic rate operates 40 percent slower than average for children of her age, causing her body to store energy rapidly and gain weight easily.

Following the initial test results, the family faced unresolved questions regarding future management, potential medications, and long-term outlooks, coupled with findings that Sara experienced gross motor skill delays alongside advanced fine motor skills. Initial consultations yielded few concrete solutions, prompting the family to consult a homeopaat without securing a lasting intervention.

Television Program Intervention and Medical Review

Weeks later, Melanie received contact from the television program Diagnose Gezocht after her mother submitted an application on their behalf. Although RTL ultimately cancelled the program before a scheduled meeting with professor Hugo Heymans could be filmed, the network provided behind-the-scenes assistance by sending Professor Hugo Heymans directly to the family home.

Professor Heymans spoke with Sara’s attending physician and reviewed her medical file, offering an explanation that clarified the condition. Jullie moeten het zien alsof Sara’s lichaam op de eco-stand staat. Haar lichaam slaat alles op en verbrandt maar een klein deel van de energie. En zoals bij elke medische aandoening kunnen de symptomen verschillen. Sara mist dus het onverzadigbare.

This explanation provided clarity on Sara’s metabolic function and renewed the family’s engagement with her primary physician for ongoing guidance and support.

Subsequent Medical Developments

Medical research progressed further when a treatment was introduced in the medical field. Following additional clinical evaluations and discussions, Sara qualified to participate in the large-scale testing phase for the new medication.